The effect of GHRH antagonists on human glioblastomas and their mechanism of action (Q39738382)

14 September 2017

title

The effect of GHRH antagonists on human glioblastomas and their mechanism of action (English)

1 reference

14 September 2017

Andrew V Schally

2

0 references

Irving Vidaurre

series ordinal

5

object named as

Irving Vidaurre

1 reference

14 September 2017

6

Szabolcs Bellyei

1 reference

14 September 2017

Eva Pozsgai

1

1 reference

14 September 2017

Marta Zarandi

series ordinal

3

1 reference

14 September 2017

Jozsef L Varga

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

International Journal of Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

127

1 reference

14 September 2017

issue

10

1 reference

14 September 2017

page(s)

2313-2322

1 reference

HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25259

Crossref

reference URL

Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Effects of growth hormone-releasing hormone-related peptide on stem cell factor expression in cultured rat Sertoli cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Present and future treatment of pancreatic cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Peptide analogs in the therapy of prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Peptides derived from pro-growth hormone-releasing hormone activate p38 mitogen-activated protein kinase in GH3 pituitary cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

The future of therapy for glioblastoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Oligomerization, chaperone activity, and nuclear localization of p26, a small heat shock protein from Artemia franciscana.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Growth hormone-releasing hormone stimulates mitogen-activated protein kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Pancreatic cancer biology and genetics

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

New approaches to the therapy of various tumors based on peptide analogues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of growth hormone-releasing hormone in oncology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Cancer statistics, 2002

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Frequent activation of AKT2 kinase in human pancreatic carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/IJC.25259

Identifiers

DOI

10.1002/IJC.25259

1 reference

14 September 2017

1 reference